|
Versapen-kDrug - Versapen-k The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Hetacillin Potassium
Strength -
EQ 225MG AMPICIL
Applicant -
BRISTOL
New Drug Application (NDA) Number -
061396
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Laboratories Inc Div Bristol Myers Co
Versapen-k
Sodium Heparin 10,000 Units/ml Injectable; Injection
Sodium Heparin 20,000 Units/ml Injectable; Injection Sodium Heparin 5,000 Units/ml Injectable; Injection Sodium Heparin 1,000 Units/ml Injectable; Injection Versapen Eq 112.5mg Ampicil/5ml For Suspension; Oral Versapen Eq 112.5mg Ampicil/ml For Suspension; Oral Versapen Eq 112.5mg Ampicil/ml For Suspension; Oral Versapen Eq 225mg Ampicil/5ml For Suspension; Oral Versapen-k Eq 225mg Ampicil Capsule; Oral Panheprin 5,000 Units/ml Injectable; Injection NewDrugInformation |